Bupropion Impurity 13 | CAS 87427-61-0 - Request Quote
Bupropion Impurity 13
| SZ CAT No: | SZ-B001034 |
| CAS No | 87427-61-0 |
| Mol.F. | C9H7BrCl2O |
| Mol.Wt. | 282.0 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Bupropion Impurity 13 is chemically 2-Bromo-1-(3,4-dichlorophenyl)propan-1-one. Bupropion Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Bupropion Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bupropion.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 87427-61-0
Purchase 87427-61-0
Order 87427-61-0
Enquire 87427-61-0
price of 87427-61-0
87427-61-0 Supplier
87427-61-0 Manufacturer
87427-61-0 Exporter
buy high quality Bupropion Impurity 13
Purchase Bupropion Impurity 13
Bupropion Impurity 13 suppliers
Bupropion Impurity 13 manufacturers
Bupropion Impurity 13 price
Order Bupropion Impurity 13
Enquire Bupropion Impurity 13
Bupropion Impurity 13 cost
Bupropion Impurity 13 Supplier
Bupropion Impurity 13 Distributor
Bupropion Impurity 13 for Method Validation
Bupropion Reference Standard
Bupropion Impurity 13 for ANDA Filing
Bupropion Impurity 13 for Forced Degradation Studies
Bupropion Impurity 13 Identification Standards
Bupropion Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.